MarketsSingle-source
2.1
Double Bond Pharma reports Q2 2026 operating loss of 0.6 million SEK
Dagens IndustriLO·SE·1 day ago
Transiro reported a widened operating loss of 2.0 million SEK for Q2 2026 compared to 0.4 million SEK in the prior year period, alongside a decline in net sales to 6.4 million SEK. The company attributed the performance to one-off items, though the specific nature of these costs remains undisclosed.